Replies to post #2763 on Momenta Pharmaceuticals, Inc. (MNTA)

[Rocky3]

Does anyone think the stock would be trading higher if they didn't have the additional $100 mil in the bank?

I do think the continued earnings are important to the stock price. I don't think that the $57MM raised in the offering at under $15/sh is helping at all. If quarterly cash flow is at the $40-50MM level, why did it raise ~one quarter's income unless it was pretty sure that tLov was very close to approval. If tLov was approved that quickly, the whole basis for MNTA's story was in question.

The price would have recovered a lot quicker without the offering, and, more importantly, the company would have a much stronger study to tell.

As always, JMO.